Amgen’s Phase III data supports FDA label expansion of Repatha
Repatha is now the first and only PCSK9 inhibitor to demonstrate significant reduction of cardiovascular events as both primary and secondary prevention
Repatha is now the first and only PCSK9 inhibitor to demonstrate significant reduction of cardiovascular events as both primary and secondary prevention
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
The acquisition positions ACL Digital as an end-to-end provider of global clinical research and data CRO solutions
Eliquis (apixaban) available at more than 40 per cent discount; Sotyktu to be offered at more than 80 per cent discount to current list price
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
The inspection was carried out between May 26, 2025 and May 31, 2025
Brenntag will supply Food & Nutrition customers in the United States and Canada with Lallemand’s renowned Nutrilife baking enzyme range
Four FDA-approved products strengthen portfolio and reaffirm commitment to global reach
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
Subscribe To Our Newsletter & Stay Updated